Riskpilot← Back to searchSign inGet full accessBØDALEN UTVIKLING AS
ASActiveOrg 927365065Olav Vs Gate 5, 7. Etasje, 0161 OsloDevelopment of building projects · NACE 6812Est. 20210 employees
Revenue 2025
NOK 0
EBITDA margin
—
-360% vs 2024
Equity ratio
-1327.2%
Financial strength
Net profit 2025
NOK -383K
-983% vs 2024
| Revenue | NOK 0 | — |
| EBITDA | NOK -86K | -360% |
| Net profit | NOK -383K | -983% |
| Total assets | NOK 78K | -82% |
| Equity | NOK -1M | -58% |
| Employees | 0 | — |
Legal name
BØDALEN UTVIKLING AS
Org number
927365065
Legal form
Aksjeselskap
NACE code
6812 · Development of building projects
Founded
1. juli 2021
Share capital
NOK 300 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Utvikling, kjøp og salg av fast eiendom, drift og eie av eiendom, samt annet som står i naturlig forbindelse med dette.
Address
Olav Vs Gate 5, 7. Etasje, 0161 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −1 069 | −34 | −19 | −19 | −86 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −1 069 | −34 | −19 | −19 | −86 |
| Net financials | −7 | −25 | −26 | −27 | −27 |
| Profit before tax | −1 076 | −59 | −44 | −45 | −114 |
| Tax | −237 | −13 | −10 | −10 | 269 |
| Net profit | −839 | −46 | −35 | −35 | −383 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 581 | 453 | 439 | 432 | 78 |
| Equity | −539 | −586 | −620 | −655 | −1 038 |
| Long-term debt | 1 000 | 1 033 | 1 058 | 1 085 | 0 |
| Short-term debt | 121 | 6 | 1 | 2 | 5 |
| Total debt | 1 121 | 1 038 | 1 059 | 1 087 | 1 117 |
EBITDA margin
-8639400.0%
This company
15.8%
Market median
-54679847% vs market
20212025
Equity ratio
-1327.2%
This company
38.2%
Market median
-3574% vs market
20212025
Return on equity
-38301100.0%
This company
18.4%
Market median
-208158252% vs market
20212025
Net profit margin
-38301100.0%
This company
8.1%
Market median
-472853186% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
1.08×
This company
0.62×
Market median
-74% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-06-03 – 2021-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MH Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Scan Chemicals As | Company | 20.0% | 20.0% | 2024 |
Alden As | Company | 20.0% | 20.0% | 2024 |
Haadem Invest As | Company | 20.0% | 20.0% | 2024 |
Quarten As | Company | 20.0% | 20.0% | 2024 |
| Individual | 10.0% | 10.0% | 2024 | |
| Individual | 10.0% | 10.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BØDALEN UTVIKLING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Morten Hotvedt | Chief Executive Officer | 0 companies |
| Edvin Austbø | Board of Directors | 0 companies |